Indicated for the treatment of stenoses in the upper extremity venous outflow of patients dialyzing with an AV access graft or fistula and for the treatment of atherosclerotic lesions in iliac and femoral arteries with a reference vessel diameter of 4.5–9 mm
–
BD Interventional
Covera Vascular Covered Stent
Nitinol, ePTFE-covered stent
8, 9
0.035
6, 7, 8, 9,10
30, 40, 60, 80, 100
80, 120
Indicated for use in hemodialysis patients for the treatment of stenoses in the venous outflow of an arterio-venous (AV) fistula and at the venous anastomosis of an ePTFE or other synthetic AV graft
–
BD Interventional
Fluency Plus Endovascular Stent Graft
Nitinol/ePTFE
8, 9, 10
0.035
5, 6, 7, 8, 9, 10, 12, 13.5
20, 30, 40, 60, 80, 100, 120
80, 117
Residual stenosis with impaired perfusion (pressure gradient) after balloon dilatation, especially in stages III and IV according to Fontaine; dissection; detached arteriosclerotic plaque material and luminal obstruction after balloon dilatation; occlusion after thrombolysis or after aspiration and before dilatation; restenosis or reocclusion
–
Gore & Associates
Gore Viabahn Endoprosthesis With Propaten Bioactive Surface
Nitinol/ePTFE, gold
6–10
0.018/0.014 (5–8 mm), 0.035 (5–13 mm)
5, 6, 7, 8, 9, 10, 11, 13
25, 50, 75, 100, 150, 250
75 (0.035-inch system only), 120
Indicated for the treatment of de novo or restenotic lesions in the iliac arteries; de novo or restenotic lesions in the superficial femoral artery and proximal popliteal artery; in-stent restenotic lesions in the superficial femoral artery and proximal popliteal artery; stenosis or thrombotic occlusion at the venous anastomosis of synthetic arteriovenous (AV) access grafts and in the venous outflow of dialysis access circuits, including the central veins; popliteal artery aneurysms and isolated visceral artery aneurysms; traumatic or iatrogenic vessel injuries in arteries that are located in the chest cavity, abdominal cavity, or pelvis (except for aorta, coronary, innominate, carotid, vertebral, and pulmonary arteries)
–
Gore & Associates
Gore Viabil Biliary Endoprosthesis
Nitinol/ePTFE
8.5 (endoscopic), 10 (percutaneous)
0.035
8, 10
40, 60, 80, 100
40 (percutaneous), 200 (endoscopic)
Benign* and malignant biliary strictures†
*Devices without transmural drainage holes; †Contraindicated for all cardiovascular applications
Flexible self-expanding endoprosthesis indicated for use in hemodialysis patients for the treatment of stenosis or occlusion within the dialysis outflow circuit of an arteriovenous (AV) fistula or AV graft
The 6-10-mm-diameter stents come in lengths of 50, 75, 100, and 125 mm; the 12-, 14-, and 16-mm-diameter stents come in lengths of 30, 40, 50, 60, 70, and 80 mm
Scitech Medical
Solaris
Nitinol/PTFE
9
0.035
6–9
40, 60, 80
130
In the treatment of in-stent restenosis in the venous outflow of hemodialysis patients dialyzing by either an arteriovenous (AV) fistula or AV graft; in the treatment of stenosis in the venous outflow of hemodialysis patients dialyzing by an AV graft; restenosis or reocclusion (except vessels on the central circulatory system and central nervous system); dissection (except vessels on the central circulatory system and central nervous system); residual stenosis with impaired perfusion (pressure gradient) following balloon dilatation, especially in stages III and IV according to Fontaine (except vessels on the central circulatory system and central nervous system); detached arteriosclerotic plaque material and luminal obstruction following balloon dilatation (except vessels on the central circulatory system and central nervous system); occlusion after thrombolysis or after aspiration and before dilatation (except vessels on the central circulatory system and central nervous system)
Precise deployment, high flexibility, minimal shortening, balanced radial strength
Boston Scientific Corporation
Wallgraft Endoprosthesis With Unistep Plus Delivery System
Superalloy wire/polyethylene terephthalate graft material
9–12
0.035
6–10, 12, 14
20, 30, 50, 70
–
Indicated for use for treatment of complex iliac artery stenoses (lesions ≥ 3 cm in length or calcified or eccentric lesions < 3 cm in length) and iliac occlusions in vessels 7–12 mm in diameter; the exclusion of atherosclerotic arterial aneurysms and traumatic vessel disruptions in peripheral vessels 5–12 mm in diameter
–
Advertisement
Advertisement
We value keeping the Device Guide up to date.
If you want to add or update your company’s device listings, please let us know!